Literature DB >> 18246389

Walz aldosteronoma.

Elizabeth G Grubbs1, Jeffrey E Lee.   

Abstract

Mesh：

Year:  2008        PMID： 18246389     DOI： 10.1007/s00268-007-9420-9

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  6 in total

1.  Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia.

Authors:  Yuri W Novitsky; Kent W Kercher; Michael J Rosen; William S Cobb; Sathya Jyothinagaram; B Todd Heniford
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

2.  Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas.

Authors:  Yah Yuen Tan; Jennifer B Ogilvie; Frederick Triponez; Nadine R Caron; Electron K Kebebew; Orlo H Clark; Quan-Yang Duh
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

3.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

Review 4.  Low renin hypertensive states: perspectives, unsolved problems, future research.

Authors:  Richard D Gordon; John H Laragh; John W Funder
Journal:  Trends Endocrinol Metab       Date:  2005-04       Impact factor: 12.015

5.  Management of the clinically inapparent adrenal mass ("incidentaloma").

Authors:  Melvin M Grumbach; Beverly M K Biller; Glenn D Braunstein; Karen K Campbell; J Aidan Carney; Paul A Godley; Emily L Harris; Joseph K T Lee; Yolanda C Oertel; Mitchell C Posner; Janet A Schlechte; H Samuel Wieand
Journal:  Ann Intern Med       Date:  2003-03-04       Impact factor: 25.391

6.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.